The mechanism of action of metformin involves phosphorylation of LKB-1, which activates AMP-activated protein kinase (AMPK) and consequently inhibits the mammalian target of rapamycin (mTOR) pathway, leading to growth inhibition of cancer cells. The gene discussed is MTOR; the disease is cancer.